Home > Income Statement > AARTI PHARMALABS

AARTI PHARMALABS
Revenue

    Back to Income Statement
AARTI PHARMALABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,945 Cr₹1,200 Cr--

What is the latest Revenue of AARTI PHARMALABS ?

The latest Revenue ratio of AARTI PHARMALABS is ₹1,945 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹1,945 Cr
Mar2023₹1,200 Cr
Mar2022-
Mar2021-

How is Revenue of AARTI PHARMALABS Trending?

Years Revenue % Change
Mar2024 ₹1,945 Cr
62.11
Mar2023 ₹1,200 Cr
0
Mar2022 -
0
Mar2021 - -

Compare Revenue of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹8,192.5 Cr 3.6% 28.3% 55.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,125.0 Cr 0.1% -9.1% 13.3% Stock Analytics
DIVIS LABORATORIES ₹173,358.0 Cr -1.6% 6.5% 47% Stock Analytics
CIPLA ₹118,957.0 Cr 0.3% -4.6% -1.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,087.0 Cr -0.9% -4.5% 15.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,197.0 Cr 0.4% 6.5% 4.1% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

3.6%

28.3%

55.6%

SENSEX

-1%

0.3%

7.4%


You may also like the below Video Courses